Australian Clinical Labs Ltd: A Comprehensive Overview

Australian Clinical Labs Limited, a prominent player in the health care sector, operates primarily in Australia, offering a wide range of pathology services. The company specializes in routine pathology tests, trimester screening, haematology, histopathology, immunology, and microbiology services. Based in Clayton, the company has established a strong presence, catering to customers across the nation.

As of June 12, 2025, the close price of Australian Clinical Labs Ltd’s stock was AUD 2.73. The company’s stock has experienced fluctuations over the past year, with a 52-week high of AUD 3.855 on October 14, 2024, and a 52-week low of AUD 2.32 on July 9, 2024. The market capitalization stands at AUD 553,820,000, reflecting its significant presence in the health care sector.

The company’s financial metrics include a price-to-earnings ratio of 18.31, indicating its valuation relative to its earnings. This ratio provides investors with insight into the company’s financial health and market expectations.

Australian Clinical Labs Ltd is listed on the ASX All Markets, providing investors with the opportunity to trade its shares. For those interested in learning more about the company’s offerings or seeking updates, information is readily available on their official website, www.clinicallabs.com.au .

In summary, Australian Clinical Labs Limited continues to be a key provider of health care services in Australia, with a strong market presence and a diverse range of pathology services. The company’s financial performance and market position make it a noteworthy entity in the health care sector.